Efficacy of interferon beta-1a plus remdesivir compared to remdesivir alone in hospitalised adults with COVID-19: a phase 3 double-bind, randomised, placebo-controlled trial (Adaptive COVID-19 Treatment Trial (ACTT-3)) The Lancet Respiratory Medicine Study team, M. 2021

View details for DOI 10.1016/S2213-2600(21)00384-2